logo
What to know about chikungunya, the virus spreading in southern China as heavy rain brings floods

What to know about chikungunya, the virus spreading in southern China as heavy rain brings floods

Globe and Mail4 days ago
Chinese authorities have taken measures this week to try to curb the spread of chikungunya, a virus that often causes fever and joint pain.
As of Wednesday, the government reported there had been more than 7,000 cases, mostly in the southern manufacturing hub of Foshan.
Monsoon in southern China unleashes landslides, threatens to worsen chikungunya outbreak
Here's what to know about chikungunya.
Chikungunya is a disease caused by a virus of the same name.
The chikungunya virus was first identified in people sickened during an outbreak in Tanzania in 1952. Its name is derived from a word in the Makonde language, which means 'that which bends up,' due to the severe pain it can cause.
Chikungunya is transmitted by infected mosquitoes and mostly causes mild symptoms. The majority of people who get chikungunya recover without needing medical attention after one to two weeks.
Chikungunya typically produces symptoms including fever, muscle pain, nausea, fatigue and a rash.
But in rare cases, it can cause debilitating joint pain that persists for months or even years. Patients who get severely ill often require hospitalization because of the risk of organ damage.
The World Health Organization says severe cases and deaths are rare and mostly occur in babies or elderly people with underlying health conditions.
There is no specific treatment for chikungunya, but health workers can treat the symptoms by giving medicines to lower fevers or ease muscle pain.
Two vaccines have been approved in several regions, including Britain, Brazil, Canada and Europe. Those are mostly targeted at travellers and are not widely available in the countries most affected by chikungunya.
Chikungunya causes regular outbreaks in Africa, Asia and the Americas, with occasional small epidemics in Europe.
As of July, there have been about 240,000 cases of chikungunya, including 90 deaths in 16 countries, according to the European Centres for Disease Prevention and Control. The countries that reported the highest number of infections were Brazil, Bolivia, Argentina and Peru.
An outbreak of chikungunya in Foshan, near Hong Kong, has prompted Chinese authorities to take measures like distributing mosquito nets, having workers spray residential areas, streets and construction sites with insecticide.
People who do not empty bottles, flower pots or other outdoor receptacles, where water might accumulate and allow mosquitoes to breed, can be subject to fines of up to 10,000 yuan ($1,915) and have their electricity cut off.
The U.S. has issued a travel advisory telling citizens not to visit China's Guangdong province, the location of Donguan and several other business hubs, along with countries such as Bolivia and island nations in the Indian Ocean.
Unusually heavy rains and high temperatures this year have worsened the crisis in China.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Ontario announces new publicly funded surgical and diagnostic centres in Windsor
Ontario announces new publicly funded surgical and diagnostic centres in Windsor

CTV News

timea day ago

  • CTV News

Ontario announces new publicly funded surgical and diagnostic centres in Windsor

A new investment from the provincial government is looking to slash wait times for certain procedures in the city. CTV Windsor's Chris Campbell explains. Three new community surgical and diagnostic centres in Windsor have been approved to deliver publicly funded procedures as part of the Ontario government's plan to reduce wait times and expand access to care. Windsor-Tecumseh MPP Andrew Dowie made the announcement Friday at RAAMP Endoscopy in Windsor, noting that the local expansion is part of a broader $155-million provincial investment to add 57 licensed centres across Ontario. The province said the initiative will connect up to 1.2 million patients to faster access for MRIs, CT scans, and gastrointestinal (GI) endoscopies over the next two years. The newly approved Windsor facilities include RAAMP Endoscopy and Rose City Endoscopy, which will offer GI endoscopy procedures, and GMNI MRI/CT Windsor, which will provide MRI and CT scans. Licensing is expected to begin as early as summer 2025. 'The Government of Ontario is proud to strengthen and expand access to health care by delivering faster, more convenient diagnostic services in Windsor-Essex,' said Dowie. 'The launch of RAAMP Endoscopy and Rose City Endoscopy, along with expanded MRI and CT services at GMNI MRI/CT Windsor, marks a significant step forward for our region and the province as a whole.' RAAMP Endoscopy is expected to be licensed in 2026, while Rose City Endoscopy is scheduled for 2025. GMNI MRI/CT Windsor is expected to begin providing both MRI and CT services in 2026. Dr. Wassim Saad, president of RAAMP Endoscopy, said the new centre will help reduce wait times for essential procedures locally. 'The addition of RAAMP Endoscopy means our residents will have better, faster access to essential procedures – right here at home,' Saad said. 'We are deeply grateful to the Ontario government, the Ministry of Health and MPP Dowie for recognizing the needs of our community and investing in solutions that will improve health outcomes for thousands of people.' Ontario surgical announcement Windsor Aug 8 Ontario announced three new surgical and diagnostic centres to offer publicly funded procedures in Windsor, Ont. on Aug. 8, 2025. (Chris Campbell/CTV News Windsor) Dr. Saad also serves as chief of staff at Windsor Regional Hospital, a dual role that could raise questions about potential conflict of interest. He said his plans to apply for the provincial licenses were fully disclosed to the hospital's leadership. 'I made my intentions to apply for these licenses very clear to both my CEO and to the board of directors. They were very supportive,' Saad said. 'They understand that this is helping the hospital, and it's offloading the acute care. During the application process, we also took a position at the hospital that we were not going to publicly endorse, or even, as part of the application process, endorse any one particular applicant, including mine.' Rose City Endoscopy, which has operated in Windsor since 2012, is among 22 new GI endoscopy centres licensed across the province. Its medical director said government funding will allow the clinic to further expand services. 'Rose City Endoscopy has been a leader in outpatient gastrointestinal endoscopy in our region with 50,891 outpatient gastrointestinal procedures to date,' said Dr. Vladislav Khokhotva. 'While a significant percentage of our funding is still going to be provided by our doctors, the addition of government funding will allow us to develop our facility further to a top world-class level.' The province said the 22 newly licensed GI centres will add up to 420,000 endoscopy procedures over two years — more than triple its original target. Meanwhile, 35 new MRI/CT centres are expected to provide diagnostic imaging for up to 828,000 additional patients. RAAMP Endoscopy RAAMP Endoscopy seen in Windsor, Ont. on Aug. 8, 2025. (Chris Campbell/CTV News Windsor) Deputy Premier and Minister of Health Sylvia Jones said the announcement builds on efforts to clear surgical and diagnostic backlogs across the province. 'When it comes to wait times for surgeries and procedures, the status quo is not acceptable,' said Jones. 'That's why our government is taking bold, decisive action to protect Ontario's health-care system by boosting access to vital surgeries and diagnostic imaging so that families can conveniently access the care they need sooner.' As part of the government's broader plan, titled Your Health: A Plan for Connected and Convenient Care, community surgical and diagnostic centres have increasingly been used to deliver publicly funded care outside of hospital settings. According to the province, these facilities are not allowed to charge patients for insured services or allow patients to pay for faster access. Quality assurance inspections are carried out through Accreditation Canada, with new standards introduced in 2024. There are more than 900 such community-based facilities across Ontario, most of which provide diagnostic imaging.

Hand, foot and mouth disease cases are popping up in Edmonton. What is it and how can you avoid it?
Hand, foot and mouth disease cases are popping up in Edmonton. What is it and how can you avoid it?

CTV News

timea day ago

  • CTV News

Hand, foot and mouth disease cases are popping up in Edmonton. What is it and how can you avoid it?

An Edmonton emergency room doctor says she's seeing a number of cases of hand, foot and mouth disease. Dr. Shazma Mithani says it's not entirely surprising, as cases tend to pop up around the end of the summer. 'I am seeing some cases in the emergency room, and also in talking to many friends of mine who have younger kids in daycare, there are outbreaks in a lot of places right now,' she told CTV News Edmonton. The illness is caused by a virus and presents as a rash on the palms, the soles of the feet, around the buttocks, and on the face and mouth. 'Blisters occur around the mouth, in the mouth, on the roof of the mouth, the back of the throat; those are pretty classic for hand, foot and mouth,' Mithani said. 'Other things that you can see in addition to the rash are things like a fever. Sometimes you can get a bit of a runny nose, and diarrhea can be common with hand, foot and mouth disease as well.' It's spread through contact and droplets. Mithani says the virus is found in bodily fluids and fecal material. It also lives inside the blisters of someone infected with the disease. She says toddlers and younger school children are most at risk for getting sick, because their hygiene isn't as good as that of older children. 'Kids, especially younger kids, aren't so diligent about washing hands,' she said. 'By the time kids are older, they've likely already been exposed to the viruses that cause hand, foot and mouth disease, so they do have some immunity to it as they get older.' Despite that, Mithani says you can catch the disease more than once. 'Hand, foot and mouth disease does not have a vaccine, and it is one that you can get multiple times, especially because there are a few different viruses that cause this disease syndrome,' she noted. Mithani says the best way to prevent hand, foot and mouth disease is to practice good hand hygiene. If you or your child becomes sick, there are a few things to consider. 'These blisters can be quite painful, especially in the mouth, and that can impact your child's ability to take in fluids and be at risk of getting dehydrated,' she said. 'Making sure pain is controlled with medications like acetaminophen or ibuprofen, making sure that fever is controlled with that as well, and then keeping up with fluids.' She also urges parents to keep their children home from school if they get sick. It's a sentiment echoed by Edmonton's school boards as kids get ready to head back to classes. 'The health and well-being of students and staff is a priority for the division and schools,' Lauren Arscott of Edmonton Public wrote in an email to CTV News Edmonton. 'We want to remind parents, when the school year begins, to keep their children home if they show any signs of illness.' 'We encourage families to keep students at home should they feel unwell to help prevent the spread of illness,' a spokesperson for Edmonton Catholic Schools said. With files from CTV News Edmonton's Nahreman Issa

Hologic's Diagnostics Arm Set for Long-Term Upside: What's Behind It?
Hologic's Diagnostics Arm Set for Long-Term Upside: What's Behind It?

Globe and Mail

time2 days ago

  • Globe and Mail

Hologic's Diagnostics Arm Set for Long-Term Upside: What's Behind It?

Hologic 's HOLX Diagnostics unit, the largest by revenues, has been the most impacted by geopolitical headwinds this year. Cuts in USAID funding have affected its HIV testing business in Africa, while a challenging operating environment in China has weighed on its Cytology business. As a result, Diagnostics posted just 0.9% year-over-year reported growth in the third quarter of fiscal 2025. Despite these hurdles, the underlying growth drivers in the segment continue to remain strong. One is the BV, CV/TV assay, which has become Hologic's second-largest assay globally after shifting from a primarily lab-developed test (LDT) approved in 2019 to an in-vitro diagnostics (IVD) test on the high-throughput Panther instrument. The company is working to reach the estimated 60% of U.S. women who are not tested when they experience vaginitis, applying the same approach it uses to expand sexually transmitted infection (STI) testing. Additionally, Panther Fusion, an add-on module to the base Panther platform, is gaining nice traction this year as customers adopt more menus. The system uses PCR chemistry to run Hologic's suite of respiratory assays, including influenza, while offering an expanded IVD menu and Open Access functionality for LDTs. Open Access testing kits contributed to Fusion's solid growth in the fiscal third quarter. Over the next several years, Hologic plans to broaden the menu by launching an IVD test for GI and hospital-acquired infections, positioning the sidecar to play a key role in future Diagnostics growth. The company is also currently in the early stages of its Biotheranostics opportunity. Acquired in 2021, the asset marked Hologic's entry into the lab-based oncology space, an expanding and longtime area of interest. Biotheranostics' Breast Cancer Index test — the only commercially available test validated to inform the decision regarding extended endocrine therapy — continues to see strong adoption. Latest Updates From Hologic's Diagnostics Peers Abbott 's ABT Diagnostics sales declined 1.5% in the second quarter of 2025, mainly due to the year-over-year decrease in COVID-19 testing sales and the impact of volume-based procurement programs in China. Together, these are expected to weigh on ABT's full-year Diagnostics sales growth by around $700 million or 750 basis points. Excluding China, Abbott's Core Lab Diagnostics grew 8%, reflecting strong underlying demand in the global markets. Danaher 's DHR core sales growth in the molecular diagnostics business witnessed growth in the second quarter of 2025, as gains in non-respiratory testing more than offset declines in core sales of respiratory tests. Danaher also announced a new partnership with AstraZeneca to develop diagnostic tools that identify patients most likely to benefit from precision medicine treatments. This collaboration is leveraging the newly launched Danaher Centers to enable precision medicine to streamline the end-to-end development process. HOLX Stock Performance, Valuation and Estimates Year to date, Hologic shares have declined 5.8% compared with the industry's 11.7% fall. Hologic is trading at a forward five-year price-to-earnings of 15.05X, lower than the industry average of 27.49X. The stock carries a Value Score of B at present. Image Source: Zacks Investment Research See how analysts are projecting Hologic's EPS for fiscal 2025 and 2026. HOLX stock currently carries a Zacks Rank #3 (Hold).You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. See our %%CTA_TEXT%% report – free today! 7 Best Stocks for the Next 30 Days Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Abbott Laboratories (ABT): Free Stock Analysis Report Danaher Corporation (DHR): Free Stock Analysis Report Hologic, Inc. (HOLX): Free Stock Analysis Report This article originally published on Zacks Investment Research (

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store